{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:11:43Z","timestamp":1792141903162,"version":"4.4.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007338","name":"Foundation for Barnes-Jewish Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007338","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.msard.2025.106268","type":"journal-article","created":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T16:21:35Z","timestamp":1736612495000},"page":"106268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Cerebrospinal fluid biomarkers as predictors of multiple sclerosis severity"],"prefix":"10.1016","volume":"94","author":[{"given":"Miguel","family":"Tolentino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Pace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana C.","family":"Perantie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Mikesell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Huecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim","family":"Chahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ghezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Piccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0829-7569","authenticated-orcid":false,"given":"Anne H.","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.msard.2025.106268_bib0001","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1177\/1352458512473362","article-title":"CXCL13 is a biomarker of inflammation in multiple sclerosis, neuromyelitis optica, and other neurological conditions","volume":"19","author":"Alvarez","year":"2013","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2025.106268_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104662","article-title":"Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trials","volume":"93","author":"Bar-Or","year":"2023","journal-title":"eBioMedicine"},{"issue":"1","key":"10.1016\/j.msard.2025.106268_bib0003","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1212\/WNL.42.1.63","article-title":"A correlative triad of gadolinium-DTPA MRI, EDSS, and CSF-MBP in relapsing multiple sclerosis patients treated with high-dose intravenous methylprednisolone","volume":"42","author":"Barkhof","year":"1992","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.msard.2025.106268_bib0004","doi-asserted-by":"crossref","first-page":"e271","DOI":"10.1212\/NXI.0000000000000271","article-title":"Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS","volume":"3","author":"Bergman","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"16","key":"10.1016\/j.msard.2025.106268_bib0005","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1212\/WNL.0000000000001506","article-title":"Will CSF biomarkers guide future therapeutic decisions in multiple sclerosis?","volume":"84","author":"Bielekova","year":"2015","journal-title":"Neurology"},{"issue":"26","key":"10.1016\/j.msard.2025.106268_bib0006","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1056\/NEJM197612232952604","article-title":"Radioimmunoassay of myelin basic protein in spinal fluid. An index of active demyelination","volume":"295","author":"Cohen","year":"1976","journal-title":"N. Engl. J. Med."},{"issue":"Pt 3","key":"10.1016\/j.msard.2025.106268_bib0007","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/brain\/awh714","article-title":"Age at disability milestones in multiple sclerosis","volume":"129","author":"Confavreux","year":"2006","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.msard.2025.106268_bib0008","article-title":"Intrathecally produced CXCL13: a predictive biomarker in multiple sclerosis","volume":"6","author":"DiSano","year":"2020","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"issue":"6","key":"10.1016\/j.msard.2025.106268_bib0009","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/ana.24954","article-title":"Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis","volume":"81","author":"Disanto","year":"2017","journal-title":"Ann. Neurol."},{"issue":"12","key":"10.1016\/j.msard.2025.106268_bib0010","first-page":"1120","article-title":"Clinical usefulness of oligoclonal bands]","volume":"32","author":"Falip","year":"2001","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.msard.2025.106268_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105630","article-title":"Soluble TREM2: innocent bystander or active player in neurological diseases?","volume":"165","author":"Filipello","year":"2022","journal-title":"Neurobiol. Dis."},{"issue":"417","key":"10.1016\/j.msard.2025.106268_bib0012","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/01621459.1992.10475190","article-title":"Generalized collinearity diagnostics","volume":"87","author":"Fox","year":"1992","journal-title":"J. Am. Stat. Assoc."},{"issue":"3","key":"10.1016\/j.msard.2025.106268_bib0013","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1600-0404.1992.tb05088.x","article-title":"CSF myelin basic protein, IgG and IgM levels in 101 MS patients before and after treatment with high-dose intravenous methylprednisolone","volume":"86","author":"Frequin","year":"1992","journal-title":"Acta Neurol. Scand."},{"issue":"3-4","key":"10.1016\/j.msard.2025.106268_bib0014","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000479516","article-title":"Older age at multiple sclerosis onset is an independent factor of poor prognosis: a population-based cohort study","volume":"48","author":"Guillemin","year":"2017","journal-title":"Neuroepidemiology"},{"issue":"6669","key":"10.1016\/j.msard.2025.106268_bib0015","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/35876","article-title":"A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1","volume":"391","author":"Gunn","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.msard.2025.106268_bib0016","doi-asserted-by":"crossref","DOI":"10.1177\/17562864211007687","article-title":"Inflammation in multiple sclerosis","volume":"14","author":"Haase","year":"2021","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"7","key":"10.1016\/j.msard.2025.106268_bib0017","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1177\/1352458518807101","article-title":"Prognostic information for people with MS: impossible or inevitable?","volume":"26","author":"Heesen","year":"2020","journal-title":"Mult. Scler."},{"issue":"6196","key":"10.1016\/j.msard.2025.106268_bib0018","doi-asserted-by":"crossref","DOI":"10.1126\/science.1255263","article-title":"Interneurons. Fast-spiking, parvalbumin(+) GABAergic interneurons: from cellular design to microcircuit function","volume":"345","author":"Hu","year":"2014","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.msard.2025.106268_bib0019","article-title":"Correlations between macrophage\/microglial activation marker sTREM-2 and measures of T-cell activation, neuroaxonal damage and disease severity in multiple sclerosis","volume":"7","author":"Ioannides","year":"2021","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"issue":"8","key":"10.1016\/j.msard.2025.106268_bib0020","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1523\/JNEUROSCI.10-08-02735.1990","article-title":"Alpha-internexin, a novel neuronal intermediate filament protein, precedes the low molecular weight neurofilament protein (NF-L) in the developing rat brain","volume":"10","author":"Kaplan","year":"1990","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.msard.2025.106268_bib0021","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/1352458510389102","article-title":"Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course","volume":"17","author":"Khademi","year":"2011","journal-title":"Mult. Scler."},{"issue":"10","key":"10.1016\/j.msard.2025.106268_bib0022","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"12","key":"10.1016\/j.msard.2025.106268_bib0023","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/ni1411","article-title":"The TREM receptor family and signal integration","volume":"7","author":"Klesney-Tait","year":"2006","journal-title":"Nat. Immunol."},{"issue":"Pt 1","key":"10.1016\/j.msard.2025.106268_bib0024","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/brain\/awh680","article-title":"Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment","volume":"129","author":"Krumbholz","year":"2006","journal-title":"Brain J. Neurol."},{"issue":"14","key":"10.1016\/j.msard.2025.106268_bib0025","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1212\/WNL.0b013e31821432ff","article-title":"Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis","volume":"76","author":"Kuhle","year":"2011","journal-title":"Neurology"},{"issue":"13","key":"10.1016\/j.msard.2025.106268_bib0026","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1177\/1352458519885613","article-title":"Neurofilament light levels are associated with long-term outcomes in multiple sclerosis","volume":"26","author":"Kuhle","year":"2020","journal-title":"Mult. Scler."},{"issue":"3","key":"10.1016\/j.msard.2025.106268_bib0027","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1177\/135245859800400306","article-title":"Myelin basic protein in CSF as indicator of disease activity in multiple sclerosis","volume":"4","author":"Lamers","year":"1998","journal-title":"Mult. Scler."},{"issue":"4","key":"10.1016\/j.msard.2025.106268_bib0028","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1084\/jem.187.4.655","article-title":"B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1\/CXCR5","volume":"187","author":"Legler","year":"1998","journal-title":"J. Exp. Med."},{"issue":"1-2","key":"10.1016\/j.msard.2025.106268_bib0029","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jneuroim.2006.07.006","article-title":"Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness","volume":"180","author":"Link","year":"2006","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.msard.2025.106268_bib0030","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1034\/j.1600-0404.2000.102005322.x","article-title":"Oligoclonal bands in cerebrospinal fluid: a comparative study of isoelectric focusing, agarose gel electrophoresis and IgG index","volume":"102","author":"Lunding","year":"2000","journal-title":"Acta Neurol. Scand."},{"issue":"3","key":"10.1016\/j.msard.2025.106268_bib0031","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1136\/jnnp.64.3.402","article-title":"Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis","volume":"64","author":"Lycke","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.msard.2025.106268_bib0032","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1177\/1352458519871818","article-title":"Can CSF biomarkers predict future MS disease activity and severity?","volume":"26","author":"Magliozzi","year":"2020","journal-title":"Mult. Scler."},{"issue":"Pt 4","key":"10.1016\/j.msard.2025.106268_bib0033","first-page":"1089","article-title":"Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology","volume":"130","author":"Magliozzi","year":"2007","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.msard.2025.106268_bib0034","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12974-019-1650-x","article-title":"Meningeal inflammation changes the balance of TNF signalling in cortical grey matter in multiple sclerosis","volume":"16","author":"Magliozzi","year":"2019","journal-title":"J. Neuroinflamm."},{"issue":"3","key":"10.1016\/j.msard.2025.106268_bib0035","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/acn3.51298","article-title":"CSF parvalbumin levels reflect interneuron loss linked with cortical pathology in multiple sclerosis","volume":"8","author":"Magliozzi","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2025.106268_bib0036","article-title":"Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndrome","volume":"5","author":"Makhani","year":"2019","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"issue":"23","key":"10.1016\/j.msard.2025.106268_bib0037","doi-asserted-by":"crossref","first-page":"e2457","DOI":"10.1212\/WNL.0000000000009571","article-title":"Plasma neurofilament light levels are associated with risk of disability in multiple sclerosis","volume":"94","author":"Manouchehrinia","year":"2020","journal-title":"Neurology"},{"issue":"296","key":"10.1016\/j.msard.2025.106268_bib0038","article-title":"CXCR5, the defining marker for follicular B Helper T (TFH) cells","volume":"6","author":"Moser","year":"2015","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.msard.2025.106268_bib0039","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/1352458516639384","article-title":"Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis","volume":"23","author":"Novakova","year":"2017","journal-title":"Mult. Scler."},{"issue":"22","key":"10.1016\/j.msard.2025.106268_bib0040","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1212\/WNL.0000000000004683","article-title":"Monitoring disease activity in multiple sclerosis using serum neurofilament light protein","volume":"89","author":"Novakova","year":"2017","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.msard.2025.106268_bib0041","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1177\/1352458516645206","article-title":"Elevated CSF neurofilament proteins predict brain atrophy: a 15-year follow-up study","volume":"22","author":"Petzold","year":"2016","journal-title":"Mult. Scler."},{"issue":"Pt 11","key":"10.1016\/j.msard.2025.106268_bib0042","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1093\/brain\/awn217","article-title":"Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation","volume":"131","author":"Piccio","year":"2008","journal-title":"Brain J. Neurol."},{"issue":"5","key":"10.1016\/j.msard.2025.106268_bib0043","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/eji.200636837","article-title":"Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis","volume":"37","author":"Piccio","year":"2007","journal-title":"Eur. J. Immunol."},{"issue":"6","key":"10.1016\/j.msard.2025.106268_bib0044","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00401-016-1533-5","article-title":"Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status","volume":"131","author":"Piccio","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.msard.2025.106268_bib0045","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.msard.2025.106268_bib0046","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1212\/01.WNL.0000156155.19270.F8","article-title":"Multiple sclerosis severity score: using disability and disease duration to rate disease severity","volume":"64","author":"Roxburgh","year":"2005","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.msard.2025.106268_bib0047","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1046\/j.1471-4159.2002.01243.x","article-title":"Heterogeneous expression of the triggering receptor expressed on myeloid cells-2 on adult murine microglia","volume":"83","author":"Schmid","year":"2002","journal-title":"J. Neurochem."},{"issue":"23","key":"10.1016\/j.msard.2025.106268_bib0048","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1212\/WNL.0b013e3181c5b457","article-title":"Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS","volume":"73","author":"Sellebjerg","year":"2009","journal-title":"Neurology"},{"issue":"1-2","key":"10.1016\/j.msard.2025.106268_bib0049","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jns.2008.12.029","article-title":"The prognostic significance of cerebrospinal fluid in multiple sclerosis","volume":"279","author":"Siritho","year":"2009","journal-title":"J. Neurol. Sci."},{"issue":"4","key":"10.1016\/j.msard.2025.106268_bib0050","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1371\/journal.pmed.0040124","article-title":"TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis","volume":"4","author":"Takahashi","year":"2007","journal-title":"PLoS Med."},{"issue":"4","key":"10.1016\/j.msard.2025.106268_bib0051","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1084\/jem.20041611","article-title":"Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2","volume":"201","author":"Takahashi","year":"2005","journal-title":"J. Exp. Med."},{"issue":"22","key":"10.1016\/j.msard.2025.106268_bib0052","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1212\/WNL.0b013e3181c47cc2","article-title":"A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking","volume":"73","author":"Teunissen","year":"2009","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.msard.2025.106268_bib0053","doi-asserted-by":"crossref","first-page":"10381","DOI":"10.1038\/s41598-020-67504-6","article-title":"Serum neurofilament light chain predicts long term clinical outcomes in multiple sclerosis","volume":"10","author":"Thebault","year":"2020","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.msard.2025.106268_bib0054","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.msard.2025.106268_bib0055","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1600-0404.1985.tb00917.x","article-title":"CSF myelin basic protein in multiple sclerosis","volume":"72","author":"Thomson","year":"1985","journal-title":"Acta Neurol. Scand."},{"issue":"7","key":"10.1016\/j.msard.2025.106268_bib0056","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1515\/cclm-2022-0097","article-title":"Cerebrospinal fluid markers of inflammation and brain injury in Lyme neuroborreliosis - a prospective follow-up study","volume":"60","author":"Tjernberg","year":"2022","journal-title":"Clin. Chem. Lab. Med."},{"issue":"10","key":"10.1016\/j.msard.2025.106268_bib0057","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1212\/WNL.27.10.911","article-title":"Myelin encephalitogenic protein fragments in cerebrospinal fluid of persons with multiple sclerosis","volume":"27","author":"Whitaker","year":"1977","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106268_bib0058","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.689938","article-title":"Neurofilament proteins as biomarkers to monitor neurological diseases and the efficacy of therapies","volume":"15","author":"Yuan","year":"2021","journal-title":"Front. Neurosci."},{"issue":"39","key":"10.1016\/j.msard.2025.106268_bib0059","doi-asserted-by":"crossref","first-page":"10006","DOI":"10.1523\/JNEUROSCI.2580-06.2006","article-title":"Alpha-internexin is structurally and functionally associated with the neurofilament triplet proteins in the mature CNS","volume":"26","author":"Yuan","year":"2006","journal-title":"J. Neurosci."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825000124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825000124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T14:16:25Z","timestamp":1740665785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825000124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":59,"alternative-id":["S2211034825000124"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106268","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebrospinal fluid biomarkers as predictors of multiple sclerosis severity","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106268","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106268"}}